[529] GNAQ Gene Status in Cellular Blue Nevi, Spitzoid and Spindle Cell Melanomas.

Sirish Vullaganti, Patricia DeVilliers, Tatyana Isayeva, Aleodor Andea. University of Alabama at Birmingham

Background: Most benign and malignant melanocytic neoplasms display constitutive activation of the mitogen-activated protein (MAP) kinase pathway through mutations in BRAF, NRAS or HRAS genes. Recently, frequent somatic mutations of codon 209 (Q209L) in the heterotrimeric G protein a-subunit (GNAQ) gene have been reported in blue nevi (BNs) and uveal melanomas as an alternative route to MAP kinase activation. Since BNs are a heterogeneous group including common, cellular and atypical variants we aimed to investigate the differential presence of GNAQ activating mutations in BN variants which has not been reported before. In addition, GNAQ status was investigated in desmoplastic melanomas which are often confused with BNs and in Spitzoid melanomas which usually lack BRAF mutations.
Design: The study series included 9 BNs (common variant -2, cellular variant -5, atypical -1), 4 desmoplastic melanomas and 4 Spitzoid melanomas. Following microdissection of tumor from the formalin-fixed paraffin-embedded material and DNA extraction, direct sequencing of exon 5 of GNAQ gene was performed and codon 209 was analyzed for presence of the mutation.
Results: The results of mutational analysis are summarized in the table below.

 Common BNCellular BNAtypical BNSpindle Cell/Desmoplastic MelanomaSpitzoid Melanoma
No. of cases25144
GNAQ mutation (%)100%0%100%0%0%


GNAQQ209L mutations were not found in any of the cellular BNs or melanomas but were present in the common BNs.
Conclusions: While to total number of cases analyzed is low, our results suggest that within the group of blue nevi, GNAQQ209L mutations may only be present in the common form and are absent or rare in the cellular variant. This may indicate that the cellular variant of BN uses alternative mechanisms for MAP kinase activation that are different from those in common BN. In addition, no mutations were detected in the desmoplastic and Spitzoid melanomas analyzed.
Category: Dermatopathology

Tuesday, March 1, 2011 9:30 AM

Poster Session III # 120, Tuesday Morning

 

Close Window